Anbio Biotechnology  

• Booth: 3818

Anbio Biotechnology is a medical device company emphasizing in vitro diagnostics. Our mission is to change the global diagnostics market by individualizing and decentralizing the current diagnostic solutions for rapid diagnosis to improve patient prognosis. We propose this by providing rapid, accessible, and affordable diagnostic solutions globally at the forefront of science and offering innovative laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions.

 Press Releases

• Introducing the Anbio ADL i1910: An Elegant CLIA Analyzer for Comprehensive (May 10, 2024)
  The ADL i1910 utilizes a direct chemiluminescence method based on acridinium ester, ensuring accurate and reliable results across various applications. Whether it's hormone detection, myocardial disease screening, infectious disease diagnostics, or tumor-related antigen analysis, the ADL i1910 delivers exceptional performance and meets the diverse needs of modern healthcare professionals.

• Anbio introduces cutting-edge “Point of Care” technology in Europe (May 10, 2024)
  Anbio Biotechnology is expanding into the European market with its star product AF-100 C, a ground-breaking compact fluorescent immunoassay analyzer that will revolutionize point-of-care testing. With over 70 assays, the AF-100 C aims to empower healthcare providers in the EU, enhancing patient care and prognosis.

• Anbio Biotechnology to Showcase ABO & Rhd Blood Grouping Kit (May 10, 2024)

  For the first time, Anbio to showcase the ABO & Rhd Blood Grouping Kit, a qualitative detection test kit for the ABO and D antigen of the Rhd blood group system on human red blood cell in whole blood or 10% red cell suspensions in physiological saline at oversea exhibition. Anbio’s ABO & Rhd Blood Grouping Kit applies the Dot-filtration method, can acquire accurate result from fresh fingertip blood in as little as 1 minutes, with a storage time of 24 months, and it doesn't require special refrigeration or cold-chain transportation.
  
  Anbio’s ABO & Rhd Blood Grouping Kit is designed to be easy to use, simple to storage and reliable on results. Stop by Booth xxx at Medlab Middle East to speak with our representative to discover more.
   

• Introducing the Anbio LFA Solution: Rapid Diagnostic for Laboratory, Point- (May 10, 2024)
  Anbio's LFA solution is an innovative, easy-to-use, but accurate diagnostic product. The LFA solution, or Lateral Flow Assay, is a diagnostic technique for detecting antigens (s) such as viral proteins and cancer biomarkers. It has high specificity, sensitivity, and fast results, perfect for laboratory, over-the-counter (OTC), and point-of-care (POC) diagnostics.

• Introducing Anbio's Molecular RT-PCR Solution: Empowering Precision Diagnos (May 10, 2024)
  Anbio's comprehensive RT-PCR solution encompasses both pharmacogenomic and non-pharmacogenomic applications. Anbio molecular diagnostic test menu spans multiple clinical applications, including healthcare-associated infections, critical infectious disease, sexual health, virology, pharmacogenomics, and oncology. Anbio molecular diagnostic tests can be employed in institutions of any size, from small medical clinics to high-volume reference laboratories and hospitals, to access the speed and accuracy of molecular diagnostics.